Evidence map›Paper›PMID 30689772›Full record

SynthesisClinical infectious diseases : an official publication of the Infectious Diseases Society of America2019

Rapid Molecular Tests for Influenza, Respiratory Syncytial Virus, and Other Respiratory Viruses: A Systematic Review of Diagnostic Accuracy and Clinical Impact Studies.

Laura M Vos, Andrea H L Bruning, Johannes B Reitsma, Rob Schuurman, Annelies Riezebos-Brilman, Andy I M Hoepelman, Jan Jelrik Oosterheert

2 registry-linked trialsAbstract readSystematic Review
In one paragraph

Synthesis in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 53 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04245800 completednot on this map

Behavioral Patterns and Patient Self-completed Diagnostic Testing Study of Respiratory Viral Infection "Home Testing of Respiratory Illness"

TypeobservationalSponsorEvidation HealthRan2019 to 2020Enrolled5,233ConditionsInfluenza -Like Illness, Influenza A, Influenza Type B, Respiratory Viral Infection
NCT06531707 phase3unknown statusnot on this mapstarted 2024, after this paper: background citation

Efficacy and Safety of Ibuprofen/Loratadine Fixed-dose Combination Versus the Fixed-dose Administration of Monotherapy as Symptomatic Treatment for Patients With the Common Cold

TypeinterventionalSponsorLaboratorios Silanes S.A. de C.V.Ran2024 to 2025Enrolled177ConditionsCommon ColdArmsIbuprofen + Loratadine fixed dose, Ibuprofen, Loratadine
3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Guidelines for Antibiotics Prescription in Critically Ill Patients.Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Laura M VosDepartment of Infectious Diseases, University Medical Center Utrecht, Utrecht University, The Netherlands.
Andrea H L BruningDepartment of Medical Microbiology, Amsterdam University Medical Center, University of Amsterdam, The Netherlands.
Johannes B ReitsmaJulius Center for Health Sciences and Primary Care, The Netherlands.
Rob SchuurmanDepartment of Microbiology and Virology, University Medical Center Utrecht, Utrecht University, The Netherlands.
Annelies Riezebos-BrilmanDepartment of Microbiology and Virology, University Medical Center Utrecht, Utrecht University, The Netherlands.
Andy I M HoepelmanDepartment of Infectious Diseases, University Medical Center Utrecht, Utrecht University, The Netherlands.
Jan Jelrik OosterheertDepartment of Infectious Diseases, University Medical Center Utrecht, Utrecht University, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We systematically reviewed available evidence from Embase, Medline, and the Cochrane Library on diagnostic accuracy and clinical impact of commercially available rapid (results <3 hours) molecular diagnostics for respiratory viruses as compared to conventional molecular tests. Quality of included studies was assessed using the Quality Assessment of Diagnostic Accuracy Studies criteria for diagnostic test accuracy (DTA) studies, and the Cochrane Risk of Bias Assessment and Risk of Bias in Nonrandomized Studies of Interventions criteria for randomized and observational impact studies, respectively. Sixty-three DTA reports (56 studies) were meta-analyzed with a pooled sensitivity of 90.9% (95% confidence interval [CI], 88.7%-93.1%) and specificity of 96.1% (95% CI, 94.2%-97.9%) for the detection of either influenza virus (n = 29), respiratory syncytial virus (RSV) (n = 1), influenza virus and RSV (n = 19), or a viral panel including influenza virus and RSV (n = 14). The 15 included impact studies (5 randomized) were very heterogeneous and results were therefore inconclusive. However, we suggest that implementation of rapid diagnostics in hospital care settings should be considered.

Indexed as

Molecular Diagnostic TechniquesAlgorithmsClinical Decision-MakingDisease ManagementHumansInfluenza, HumanReproducibility of ResultsRespiratory Syncytial Virus InfectionsRespiratory Tract InfectionsROC CurveSensitivity and Specificitydiagnostic accuracyimpactmolecular diagnosticsrapid testreview

Identifiers

PMID30689772
PMCPMC7108200

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.